LTRN Lantern Pharma

NASDAQ
$1.00

Lantern Pharma (LTRN) is expected to report earnings on November 13, 2026, before the market open.

Lantern Pharma Reported Earnings
Friday, August 14, 2026 · 7:30 AM ET
Earnings Date
Nov 13
Friday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Lantern Pharma

Lantern Pharma is a clinical-stage oncology-focused biopharmaceutical company leveraging its proprietary RADR® AI and machine learning platform to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically-targeted therapeutics.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.